(19)
(11) EP 3 880 706 A1

(12)

(43) Date of publication:
22.09.2021 Bulletin 2021/38

(21) Application number: 19805555.0

(22) Date of filing: 07.11.2019
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
 C07K 16/32(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/32; C07K 16/2851; C07K 16/2896; C07K 2317/31
(86) International application number:
PCT/EP2019/080547
(87) International publication number:
WO 2020/099235 (22.05.2020 Gazette 2020/21)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 12.11.2018 EP 18205660

(71) Applicants:
  • MediaPharma S.r.l.
    66100 Chieti (IT)
  • Pharmamab Srl
    66100 Chieti (IT)
  • Pharmago Srl
    86100 Campobasso (IT)

(72) Inventors:
  • NATALI, Pier Giorgio
    00141 Roma (IT)
  • PIANTELLI, Mauro
    00167 Roma (IT)
  • MONCHARMONT, Bruno
    86085 Isernia (IT)
  • IACOBELLI, Stefano
    00198 Roma (IT)

(74) Representative: Heubeck, Christian 
Weickmann & Weickmann Patent- und Rechtsanwälte PartmbB Postfach 860 820
81635 München
81635 München (DE)

   


(54) BISPECIFIC ANTIBODIES DIRECTED AGAINST HUMAN 90K AND EITHER ENDOSIALIN OR HER3